Literature DB >> 16699060

Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab.

P Boura, A Sarantopoulos, I Lefaki, P Skendros, P Papadopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16699060      PMCID： PMC1798161          DOI： 10.1136/ard.2005.044685

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Drugs and Wells' syndrome: a possible causal relationship?

Authors:  D Seçkin; B Demirhan
Journal:  Int J Dermatol       Date:  2001-02       Impact factor: 2.736

2.  Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.

Authors:  Lars E French; Michael Shapiro; Jacqueline M Junkins-Hopkins; Jonathan T Wolfe; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2003-12       Impact factor: 11.527

Review 3.  Adalimumab: a review of side effects.

Authors:  Noah Scheinfeld
Journal:  Expert Opin Drug Saf       Date:  2005-07       Impact factor: 4.250

Review 4.  Nodular presentation of eosinophilic cellulitis (Wells' syndrome).

Authors:  S A Holme; P McHenry
Journal:  Clin Exp Dermatol       Date:  2001-11       Impact factor: 3.470

5.  Skin reaction to adalimumab.

Authors:  W Beuthien; H-U Mellinghoff; J von Kempis
Journal:  Arthritis Rheum       Date:  2004-05
  5 in total
  13 in total

Review 1.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

2.  Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.

Authors:  Amanda Muir; Lea Surrey; Alyssa Kriegermeier; Ala Shaikhkalil; David A Piccoli
Journal:  Am J Gastroenterol       Date:  2016-03       Impact factor: 10.864

Review 3.  Hypereosinophilia and seroconversion of rheumatoid arthritis.

Authors:  Rachel K Rosenstein; Richard S Panush; Neil Kramer; Elliot D Rosenstein
Journal:  Clin Rheumatol       Date:  2014-03-08       Impact factor: 2.980

Review 4.  Cutaneous Manifestations of Reactions to Biologics.

Authors:  Iris M Otani; Amy S Levin; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

5.  Adalimumab for the treatment of Crohn's disease.

Authors:  Andrea Cassinotti; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2008-12

6.  Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant.

Authors:  Kara Heelan; John F Ryan; Neil H Shear; Conleth A Egan
Journal:  J Dermatol Case Rep       Date:  2013-12-30

Review 7.  [Eosinophilic dermatoses].

Authors:  G Wozel
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

Review 8.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

9.  Comorbid Diagnosis of Eosinophilic Esophagitis and Inflammatory Bowel Disease in the Pediatric Population.

Authors:  Hillary Moore; Joshua Wechsler; Carrie Frost; Elizabeth Whiteside; Robert Baldassano; Jonathan Markowitz; Amanda B Muir
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288

10.  Wells syndrome associated with chronic lymphocytic leukemia.

Authors:  Petra Maria de Oliveira Duarte Stuhr; Everton Carlos Siviero do Vale
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.